| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| TOR Serine-Threonine Kinases | 52 | 2018 | 2058 | 5.960 |
Why?
|
| Multiprotein Complexes | 33 | 2017 | 1120 | 5.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 22 | 2021 | 2448 | 2.890 |
Why?
|
| Tumor Suppressor Proteins | 31 | 2022 | 2802 | 2.690 |
Why?
|
| Signal Transduction | 51 | 2024 | 23376 | 2.250 |
Why?
|
| Tuberous Sclerosis | 15 | 2022 | 1030 | 2.110 |
Why?
|
| Activating Transcription Factor 4 | 4 | 2021 | 82 | 1.750 |
Why?
|
| Lysosomes | 5 | 2022 | 920 | 1.390 |
Why?
|
| Phosphatidylinositol 3-Kinases | 13 | 2019 | 2864 | 1.370 |
Why?
|
| Protein Kinases | 14 | 2009 | 1612 | 1.310 |
Why?
|
| Metabolic Networks and Pathways | 5 | 2024 | 789 | 1.220 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 3 | 2017 | 25 | 1.190 |
Why?
|
| Proteins | 17 | 2016 | 6029 | 1.070 |
Why?
|
| Protein Biosynthesis | 7 | 2017 | 2105 | 1.060 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 4 | 2015 | 135 | 1.060 |
Why?
|
| Metabolism | 2 | 2019 | 193 | 0.920 |
Why?
|
| Ribosomal Protein S6 Kinases | 7 | 2013 | 203 | 0.850 |
Why?
|
| Purine Nucleotides | 2 | 2022 | 27 | 0.810 |
Why?
|
| Neoplasms | 18 | 2024 | 22072 | 0.750 |
Why?
|
| IMP Dehydrogenase | 1 | 2020 | 33 | 0.710 |
Why?
|
| Ribonucleosides | 1 | 2020 | 79 | 0.690 |
Why?
|
| Transcription Factors | 15 | 2014 | 12103 | 0.690 |
Why?
|
| Sirolimus | 10 | 2017 | 1547 | 0.670 |
Why?
|
| Serine | 2 | 2022 | 830 | 0.640 |
Why?
|
| Glutathione | 2 | 2021 | 582 | 0.640 |
Why?
|
| Nuclear Respiratory Factor 1 | 2 | 2015 | 21 | 0.630 |
Why?
|
| Energy Metabolism | 5 | 2019 | 2869 | 0.630 |
Why?
|
| AMP-Activated Protein Kinases | 6 | 2017 | 600 | 0.620 |
Why?
|
| Animals | 69 | 2024 | 167963 | 0.620 |
Why?
|
| NADP | 1 | 2019 | 223 | 0.610 |
Why?
|
| Amino Acids | 6 | 2022 | 1714 | 0.600 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2022 | 2873 | 0.600 |
Why?
|
| Mycophenolic Acid | 1 | 2020 | 343 | 0.600 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2017 | 4490 | 0.590 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 2 | 2015 | 56 | 0.590 |
Why?
|
| Nucleotides | 2 | 2017 | 450 | 0.580 |
Why?
|
| Insulin | 10 | 2021 | 6597 | 0.580 |
Why?
|
| Drug Resistance, Fungal | 1 | 2017 | 73 | 0.580 |
Why?
|
| Liver | 6 | 2021 | 7509 | 0.550 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 436 | 0.550 |
Why?
|
| Phosphorylation | 17 | 2019 | 8313 | 0.540 |
Why?
|
| Fatty Acids | 2 | 2022 | 1804 | 0.530 |
Why?
|
| Mice | 45 | 2022 | 81208 | 0.530 |
Why?
|
| Lipogenesis | 2 | 2015 | 210 | 0.530 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2017 | 1055 | 0.520 |
Why?
|
| Glycolysis | 4 | 2021 | 828 | 0.520 |
Why?
|
| Tetrahydrofolates | 1 | 2016 | 58 | 0.520 |
Why?
|
| Oncogene Proteins | 1 | 2019 | 719 | 0.510 |
Why?
|
| GTPase-Activating Proteins | 5 | 2022 | 475 | 0.510 |
Why?
|
| Glucose | 6 | 2021 | 4351 | 0.490 |
Why?
|
| Lipid Metabolism | 3 | 2015 | 1902 | 0.470 |
Why?
|
| HeLa Cells | 7 | 2017 | 3105 | 0.470 |
Why?
|
| Lipids | 3 | 2016 | 3336 | 0.460 |
Why?
|
| Giant Cells | 1 | 2014 | 185 | 0.460 |
Why?
|
| Purines | 2 | 2022 | 605 | 0.450 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2013 | 10 | 0.450 |
Why?
|
| Mice, Knockout | 15 | 2022 | 14372 | 0.450 |
Why?
|
| Cell Division | 5 | 2009 | 4463 | 0.450 |
Why?
|
| Repressor Proteins | 8 | 2005 | 2981 | 0.440 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2013 | 8 | 0.440 |
Why?
|
| Dihydroorotase | 1 | 2013 | 8 | 0.440 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2013 | 31 | 0.440 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2013 | 19 | 0.440 |
Why?
|
| Monomeric GTP-Binding Proteins | 5 | 2012 | 200 | 0.430 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2010 | 55 | 0.420 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 3 | 2017 | 101 | 0.420 |
Why?
|
| Models, Biological | 10 | 2012 | 9467 | 0.410 |
Why?
|
| Carrier Proteins | 6 | 2012 | 4938 | 0.410 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 3726 | 0.400 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2015 | 1313 | 0.390 |
Why?
|
| Microtubule Proteins | 3 | 2000 | 62 | 0.390 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2017 | 2698 | 0.380 |
Why?
|
| Metformin | 2 | 2017 | 912 | 0.380 |
Why?
|
| Hepatocytes | 3 | 2017 | 1229 | 0.380 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 16939 | 0.360 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 929 | 0.350 |
Why?
|
| Immunoblotting | 5 | 2017 | 1649 | 0.350 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2010 | 126 | 0.350 |
Why?
|
| Feedback, Physiological | 3 | 2011 | 476 | 0.350 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2010 | 36 | 0.340 |
Why?
|
| Cell Proliferation | 12 | 2021 | 10446 | 0.330 |
Why?
|
| RNA Interference | 7 | 2018 | 2846 | 0.330 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 363 | 0.320 |
Why?
|
| Neuropeptides | 5 | 2012 | 943 | 0.320 |
Why?
|
| Cell Line | 11 | 2021 | 15620 | 0.320 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2015 | 1728 | 0.320 |
Why?
|
| Adipocytes | 3 | 2012 | 1179 | 0.310 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2009 | 193 | 0.310 |
Why?
|
| Caenorhabditis elegans | 2 | 2016 | 1444 | 0.300 |
Why?
|
| Glioblastoma | 2 | 2021 | 3484 | 0.300 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3610 | 0.300 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 384 | 0.290 |
Why?
|
| Humans | 73 | 2024 | 760621 | 0.280 |
Why?
|
| Fibroblasts | 7 | 2021 | 4090 | 0.270 |
Why?
|
| Analgesics | 1 | 2013 | 1065 | 0.270 |
Why?
|
| Transcription, Genetic | 4 | 2016 | 7593 | 0.260 |
Why?
|
| Mitochondria | 3 | 2016 | 3600 | 0.260 |
Why?
|
| Myocardium | 1 | 2019 | 4700 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 12 | 2021 | 22023 | 0.260 |
Why?
|
| Heart | 1 | 2019 | 4393 | 0.260 |
Why?
|
| Homeostasis | 4 | 2016 | 3306 | 0.250 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 410 | 0.240 |
Why?
|
| Chromatography, Liquid | 3 | 2019 | 987 | 0.230 |
Why?
|
| HEK293 Cells | 4 | 2019 | 4264 | 0.220 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2000 | 1854 | 0.220 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2221 | 0.220 |
Why?
|
| Neurons | 2 | 2022 | 9426 | 0.210 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 11903 | 0.210 |
Why?
|
| 3T3-L1 Cells | 3 | 2013 | 209 | 0.200 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1173 | 0.200 |
Why?
|
| Phosphotransferases | 1 | 2002 | 303 | 0.200 |
Why?
|
| Feedback | 1 | 2005 | 791 | 0.190 |
Why?
|
| Animal Feed | 1 | 2021 | 112 | 0.190 |
Why?
|
| Fungal Proteins | 3 | 2000 | 911 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 621 | 0.180 |
Why?
|
| Pyrimidines | 1 | 2013 | 3016 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2000 | 1077 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 8515 | 0.180 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 230 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 4 | 2015 | 675 | 0.180 |
Why?
|
| Molecular Motor Proteins | 1 | 2000 | 105 | 0.170 |
Why?
|
| Genetic Techniques | 1 | 2002 | 428 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1617 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 2299 | 0.170 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 9530 | 0.160 |
Why?
|
| HCT116 Cells | 2 | 2017 | 402 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 5253 | 0.160 |
Why?
|
| Nitrogen Isotopes | 1 | 2019 | 85 | 0.160 |
Why?
|
| Amino Acid Sequence | 6 | 2012 | 13451 | 0.160 |
Why?
|
| Phospholipids | 1 | 2022 | 789 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2013 | 2895 | 0.160 |
Why?
|
| Amino Acids, Sulfur | 1 | 2018 | 16 | 0.160 |
Why?
|
| Food | 2 | 2013 | 771 | 0.150 |
Why?
|
| Phosphoribosylglycinamide Formyltransferase | 1 | 2017 | 3 | 0.150 |
Why?
|
| Carbon Isotopes | 1 | 2019 | 459 | 0.150 |
Why?
|
| Adenosylmethionine Decarboxylase | 1 | 2017 | 11 | 0.150 |
Why?
|
| Thymidylate Synthase | 1 | 2017 | 74 | 0.150 |
Why?
|
| Isotope Labeling | 1 | 2019 | 392 | 0.140 |
Why?
|
| Genes, Lethal | 1 | 2017 | 225 | 0.140 |
Why?
|
| Cells, Cultured | 9 | 2019 | 18957 | 0.140 |
Why?
|
| Cell Cycle | 4 | 2017 | 2934 | 0.140 |
Why?
|
| Hydrogen Sulfide | 1 | 2018 | 141 | 0.140 |
Why?
|
| Polyamines | 1 | 2017 | 133 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2019 | 1928 | 0.140 |
Why?
|
| RNA, Ribosomal | 1 | 2017 | 226 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 5 | 2017 | 6131 | 0.140 |
Why?
|
| Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 10 | 0.130 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2016 | 17 | 0.130 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 174 | 0.130 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2016 | 22 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 4319 | 0.130 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 17624 | 0.130 |
Why?
|
| Fasting | 1 | 2022 | 1603 | 0.130 |
Why?
|
| rho GTP-Binding Proteins | 1 | 1997 | 277 | 0.130 |
Why?
|
| Substrate Specificity | 3 | 2007 | 1792 | 0.130 |
Why?
|
| Glutamine | 1 | 2019 | 576 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2019 | 1189 | 0.130 |
Why?
|
| Cytosol | 1 | 2019 | 887 | 0.130 |
Why?
|
| Pressure | 1 | 2019 | 1156 | 0.130 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 350 | 0.130 |
Why?
|
| Lysophosphatidylcholines | 1 | 2015 | 77 | 0.130 |
Why?
|
| Autophagy | 2 | 2014 | 1337 | 0.120 |
Why?
|
| Brain | 1 | 2022 | 26951 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 717 | 0.120 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1674 | 0.120 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2014 | 17 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2016 | 180 | 0.120 |
Why?
|
| Triglycerides | 1 | 2022 | 2476 | 0.120 |
Why?
|
| Glutarates | 1 | 2016 | 244 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 5791 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 1343 | 0.120 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 3442 | 0.120 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 61 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2016 | 296 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2017 | 1115 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2017 | 504 | 0.110 |
Why?
|
| Cell Polarity | 2 | 2013 | 638 | 0.110 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2013 | 25 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 2222 | 0.110 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2015 | 203 | 0.110 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 1837 | 0.110 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 951 | 0.110 |
Why?
|
| Macrophage Activation | 1 | 2016 | 554 | 0.110 |
Why?
|
| Thiolester Hydrolases | 1 | 2013 | 85 | 0.110 |
Why?
|
| Hamartoma | 2 | 2005 | 235 | 0.100 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2013 | 88 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1791 | 0.100 |
Why?
|
| Fluorouracil | 1 | 2017 | 1631 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 1997 | 1167 | 0.100 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 135 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2017 | 1690 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2017 | 2627 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2017 | 1955 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2005 | 412 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2016 | 915 | 0.100 |
Why?
|
| Ferritins | 1 | 2014 | 597 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2009 | 1652 | 0.100 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2012 | 283 | 0.090 |
Why?
|
| Benzoquinones | 1 | 2011 | 198 | 0.090 |
Why?
|
| Binding Sites | 3 | 2009 | 6048 | 0.090 |
Why?
|
| Methotrexate | 1 | 2017 | 1719 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 518 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2013 | 484 | 0.090 |
Why?
|
| Drosophila | 1 | 2017 | 1492 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 167 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 3 | 2017 | 2803 | 0.090 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 866 | 0.090 |
Why?
|
| Light | 1 | 2016 | 1344 | 0.090 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 315 | 0.090 |
Why?
|
| Drosophila Proteins | 2 | 2017 | 1699 | 0.080 |
Why?
|
| Phosphothreonine | 1 | 2009 | 62 | 0.080 |
Why?
|
| Seizures | 1 | 2022 | 2917 | 0.080 |
Why?
|
| Macrophages | 2 | 2016 | 5745 | 0.080 |
Why?
|
| Phosphoserine | 1 | 2009 | 203 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2012 | 358 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 113 | 0.080 |
Why?
|
| Longevity | 1 | 2016 | 1050 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2021 | 3185 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 869 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 11071 | 0.080 |
Why?
|
| Metabolomics | 3 | 2017 | 1628 | 0.080 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 221 | 0.080 |
Why?
|
| Vertebrates | 1 | 2009 | 228 | 0.080 |
Why?
|
| Insulin Resistance | 4 | 2014 | 3959 | 0.080 |
Why?
|
| Neurofibromin 2 | 1 | 2009 | 270 | 0.080 |
Why?
|
| Cell Survival | 4 | 2019 | 5797 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3486 | 0.080 |
Why?
|
| Angiomyolipoma | 1 | 2009 | 184 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2012 | 914 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2009 | 330 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 1023 | 0.070 |
Why?
|
| Cell Enlargement | 1 | 2007 | 60 | 0.070 |
Why?
|
| Mutation | 5 | 2017 | 29932 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 256 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 3484 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 2192 | 0.070 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 3446 | 0.070 |
Why?
|
| Protein Binding | 3 | 2014 | 9335 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2009 | 449 | 0.070 |
Why?
|
| Models, Animal | 2 | 2011 | 2117 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 2 | 2018 | 1336 | 0.070 |
Why?
|
| ras Proteins | 1 | 2011 | 1052 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1167 | 0.070 |
Why?
|
| Iron | 1 | 2014 | 1786 | 0.070 |
Why?
|
| Pyrazines | 1 | 2012 | 1199 | 0.070 |
Why?
|
| Muscles | 1 | 2011 | 1581 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4550 | 0.060 |
Why?
|
| Esophageal Diseases | 1 | 2006 | 168 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2015 | 3682 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2011 | 998 | 0.060 |
Why?
|
| Multienzyme Complexes | 2 | 2008 | 666 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1737 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10827 | 0.060 |
Why?
|
| Herpesvirus 8, Human | 1 | 2006 | 255 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2004 | 1085 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2017 | 3602 | 0.060 |
Why?
|
| Pancreas | 1 | 2011 | 1677 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2009 | 5039 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2008 | 2176 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 5251 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2009 | 12766 | 0.060 |
Why?
|
| Cell Size | 1 | 2005 | 624 | 0.060 |
Why?
|
| Protein Footprinting | 1 | 2002 | 10 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2006 | 655 | 0.050 |
Why?
|
| Energy Intake | 1 | 2011 | 2129 | 0.050 |
Why?
|
| DNA Footprinting | 1 | 2002 | 97 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2011 | 2488 | 0.050 |
Why?
|
| Cell Movement | 2 | 2022 | 5206 | 0.050 |
Why?
|
| Molecular Weight | 2 | 2002 | 2186 | 0.050 |
Why?
|
| Male | 9 | 2018 | 359744 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 458 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3790 | 0.050 |
Why?
|
| Pheromones | 2 | 2000 | 93 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 5130 | 0.050 |
Why?
|
| Interleukin-4 | 2 | 2016 | 1130 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6068 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2016 | 3426 | 0.040 |
Why?
|
| Leptin | 1 | 2008 | 1591 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10181 | 0.040 |
Why?
|
| Carbon Cycle | 1 | 2019 | 15 | 0.040 |
Why?
|
| eIF-2 Kinase | 2 | 2011 | 144 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2006 | 1802 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3301 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 9585 | 0.040 |
Why?
|
| Carbon | 1 | 2022 | 669 | 0.040 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2018 | 36 | 0.040 |
Why?
|
| Genomics | 2 | 2013 | 5794 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 830 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2004 | 686 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 1999 | 439 | 0.040 |
Why?
|
| Ischemia | 2 | 2018 | 1893 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 640 | 0.040 |
Why?
|
| Burkholderia cepacia | 1 | 1996 | 22 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 2828 | 0.030 |
Why?
|
| Genes, Essential | 1 | 2017 | 184 | 0.030 |
Why?
|
| Kidney Neoplasms | 2 | 2012 | 4312 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2017 | 213 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1351 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 212 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 566 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 2015 | 197 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 1544 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 633 | 0.030 |
Why?
|
| Disease Progression | 1 | 2012 | 13502 | 0.030 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 2753 | 0.030 |
Why?
|
| DNA Primers | 1 | 1999 | 2819 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2668 | 0.030 |
Why?
|
| Naphthyridines | 1 | 2015 | 141 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 366 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2011 | 7850 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 11345 | 0.030 |
Why?
|
| Diet, Protein-Restricted | 1 | 2014 | 73 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14660 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 2418 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 2 | 2011 | 1132 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 372 | 0.030 |
Why?
|
| Thymine Nucleotides | 1 | 2013 | 59 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3539 | 0.030 |
Why?
|
| Phagosomes | 1 | 2014 | 199 | 0.030 |
Why?
|
| Chitin | 1 | 2013 | 33 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1062 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1354 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2013 | 193 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2014 | 881 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 18137 | 0.020 |
Why?
|
| Apoptosis | 1 | 2008 | 9501 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 495 | 0.020 |
Why?
|
| Microtubules | 1 | 1997 | 1072 | 0.020 |
Why?
|
| Chemokines | 1 | 2016 | 962 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 1996 | 770 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 802 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 13630 | 0.020 |
Why?
|
| Goals | 1 | 2016 | 708 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2141 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11712 | 0.020 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2012 | 183 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 613 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 8986 | 0.020 |
Why?
|
| Arachnoid | 1 | 2009 | 50 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3215 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1741 | 0.020 |
Why?
|
| Oxidative Stress | 2 | 2011 | 3106 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13262 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 423 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5496 | 0.020 |
Why?
|
| Transfection | 2 | 2009 | 5781 | 0.020 |
Why?
|
| Genome | 1 | 2016 | 1739 | 0.020 |
Why?
|
| Obesity | 1 | 2010 | 12922 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 1974 | 0.020 |
Why?
|
| Base Sequence | 1 | 1999 | 12446 | 0.020 |
Why?
|
| Phenylbutyrates | 1 | 2008 | 72 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 2919 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 1672 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 1296 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 2471 | 0.020 |
Why?
|
| Peptides | 1 | 1999 | 4354 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1398 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 129 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 1710 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3758 | 0.020 |
Why?
|
| DNA Replication | 1 | 2013 | 1412 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 557 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2006 | 356 | 0.020 |
Why?
|
| Histones | 1 | 2016 | 2583 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 1644 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2209 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6216 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2006 | 277 | 0.020 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2004 | 59 | 0.010 |
Why?
|
| Female | 5 | 2018 | 391270 | 0.010 |
Why?
|
| Phosphoproteins | 2 | 2003 | 2440 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1881 | 0.010 |
Why?
|
| Neurilemmoma | 1 | 2009 | 523 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 2138 | 0.010 |
Why?
|
| DNA Damage | 1 | 2013 | 2442 | 0.010 |
Why?
|
| Sarcoma, Kaposi | 1 | 2006 | 376 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5785 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2013 | 3442 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 814 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11481 | 0.010 |
Why?
|
| Body Weight | 1 | 2012 | 4611 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 16546 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1744 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 2000 | 62 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4742 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 299 | 0.010 |
Why?
|
| Biological Assay | 1 | 2003 | 630 | 0.010 |
Why?
|
| Meningioma | 1 | 2009 | 1221 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3280 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1693 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2006 | 3607 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2003 | 617 | 0.010 |
Why?
|
| Sucrose | 1 | 2000 | 156 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 2000 | 240 | 0.010 |
Why?
|
| Colonic Polyps | 1 | 2004 | 551 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 23711 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 891 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5870 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 1229 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2275 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 36290 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 1993 | 0.010 |
Why?
|
| Aging | 1 | 2016 | 8651 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 2913 | 0.010 |
Why?
|
| Point Mutation | 1 | 2002 | 1594 | 0.010 |
Why?
|
| Replicon | 1 | 1996 | 34 | 0.010 |
Why?
|
| Pseudomonas | 1 | 1996 | 123 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 1996 | 218 | 0.010 |
Why?
|
| DNA, Ribosomal | 1 | 1996 | 285 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 1996 | 280 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 1996 | 385 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3800 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1996 | 1071 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1996 | 756 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1996 | 1006 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1996 | 1456 | 0.010 |
Why?
|
| Phylogeny | 1 | 1996 | 2775 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 4625 | 0.000 |
Why?
|
| United States | 1 | 2016 | 72461 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2008 | 42063 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2012 | 65017 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 58995 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2006 | 80372 | 0.000 |
Why?
|
| Aged | 1 | 2006 | 169152 | 0.000 |
Why?
|
| Middle Aged | 1 | 2006 | 220352 | 0.000 |
Why?
|
| Adult | 1 | 2006 | 219994 | 0.000 |
Why?
|